Faculty Disclosures
			
				| Sandra E. Black, MD, FAAN | Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.  The institution of Dr. Black has received research support from Hoffmann-La Roche.  The institution of Dr. Black has received research support from Biogen.  The institution of Dr. Black has received research support from GE Healthcare.  The institution of Dr. Black has received research support from Eli Lilly.  The institution of Dr. Black has received research support from Genentech.  The institution of Dr. Black has received research support from NovoNordisk.  The institution of Dr. Black has received research support from UCB Biopharma.  The institution of Dr. Black has received research support from Alkahest Inc.  The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study. | 
			
				| Morris Freedman, MD, FAAN | No disclosure on file | 
			
				| Douglas Galasko, MD | Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics. | 
			
				| Jordan Grafman, PhD | Dr. Grafman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Grafman has received research support from NIH. Dr. Grafman has received publishing royalties from a publication relating to health care. | 
			
				| Andrew Kertesz, MD, FAAN | No disclosure on file | 
			
				| David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study.  The institution of Dr. Knopman has received research support from NIH. | 
			
				| James B. Leverenz, MD, FAAN | Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. | 
			
				| Mario F. Mendez, MD, PhD, FAAN | Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical 好色先生 Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate.  The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care. | 
			
				| M. M. Mesulam, MD, FAAN | Dr. Mesulam has received publishing royalties from a publication relating to health care. | 
			
				| Bruce L. Miller, MD, FAAN | Dr. Miller has nothing to disclose. | 
			
				| Murray Grossman, MD, FAAN | Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.  The institution of Dr. Grossman has received research support from NIH. | 
			
				| Daniel Kaufer, MD, FAAN | No disclosure on file | 
			
				| John Van Swieten, MD | Dr. Van Swieten has nothing to disclose. | 
			
				| Albert Lee, MD, MBBS | No disclosure on file | 
			
				| Sandra Weintraub, PhD, FAAN | Dr. Weintraub has nothing to disclose. | 
			
				| David P. Salmon, PhD | Dr. Salmon has nothing to disclose. | 
			
				| Bradley F. Boeve, MD, FAAN | Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation.  The institution of Dr. Boeve has received research support from Alector.  The institution of Dr. Boeve has received research support from EIP Pharma.  The institution of Dr. Boeve has received research support from Transposon.  The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. | 
			
				| Howard J. Rosen, MD | Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector.  The institution of Dr. Rosen has received research support from NIH.  The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities. | 
			
				| Tiffany W. Chow, MD, FAAN | Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA. | 
			
				| Argye E. Hillis, MD, MA | Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.  The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH. | 
			
				| Facundo Manes | No disclosure on file | 
			
				| Martin N. Rossor, MD, FAAN | No disclosure on file | 
			
				| Florence Pasquier, MD | Dr. Pasquier has nothing to disclose. | 
			
				| Keith A. Josephs, Jr., MD, FAAN | Dr. Josephs has nothing to disclose. | 
			
				| Joanne M. Hamilton | The institution of an immediate family member of Ms. Hamilton has received research support from Department of Veterans Affairs. | 
			
				| Adam L. Boxer, MD, PhD | An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda.  The institution of Dr. Boxer has received research support from Biogen.  The institution of Dr. Boxer has received research support from Eisai.  The institution of Dr. Boxer has received research support from Regeneron.  The institution of Dr. Boxer has received research support from NIH.  The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care. | 
			
				| Christopher Kipps, MD, MBBS | No disclosure on file | 
			
				| Aslam Khaja, MD | Dr. Khaja has nothing to disclose. | 
			
				| Carmela Tartaglia, MD | Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.  The institution of Dr. Tartaglia has received research support from NIH.  The institution of Dr. Tartaglia has received research support from University of Toronto. | 
			
				| Julene K. Johnson | No disclosure on file | 
			
				| Bradford Dickerson, MD, FAAN | Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care. | 
			
				| William W. Seeley, MD | Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics.  The institution of Dr. Seeley has received research support from NIH.  The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation.  The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD.  The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative. | 
			
				| Maria Luisa Gorno Tempini, MD, PhD | The institution of Dr. Gorno Tempini has received research support from the NIH. | 
			
				| Katherine P. Rankin, PhD | The institution of Dr. Rankin has received research support from Marcus Foundation. | 
			
				| Shawn Smyth, MD | Dr. Smyth has nothing to disclose. | 
			
				| Joel Kramer, PhD | The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care. | 
			
				| J. Vincent Filoteo, PhD | No disclosure on file | 
			
				| Yolande Pijnenburg | No disclosure on file | 
			
				|  | No disclosure on file | 
			
				| Zachary Miller, MD | Dr. Miller has nothing to disclose. | 
			
				| Stefano F. Cappa, MD | Dr. Cappa has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elservier.  The institution of Dr. Cappa has received research support from Italian Minsitry of Health. | 
			
				| Anna Karydas | No disclosure on file | 
			
				| Harro Seelaar, MD, PhD | Dr. Seelaar has nothing to disclose. | 
			
				| Jonathan D. Rohrer | Dr. Rohrer has nothing to disclose. | 
			
				| Alexis E. Nelson, MD, FAAN | Dr. Nelson has nothing to disclose. | 
			
				| Kelly Sloane, MD | The institution of Dr. Sloane has received research support from American Heart Association. | 
			
				| Amanda LaMarre | No disclosure on file | 
			
				| Kelly Landy | No disclosure on file | 
			
				| Chiadi U. Onyike, MD | Dr. Onyike has received personal compensation for serving as an employee of Rainwater Foundation. Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia Pharmaceuticals . Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata Pharmaceuticals. Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodell, DeVries, Leech & Dann.  The institution of Dr. Onyike has received research support from Alector. | 
			
				| Margaret Allred | No disclosure on file |